Literature DB >> 18298911

Role of different childbirth strategies on pelvic organ prolapse and stress urinary incontinence: a prospective study.

Lan Zhu1, Xu-ming Bian, Yan Long, Jing-he Lang.   

Abstract

BACKGROUND: Traumatic damage to fascial and muscular support structures during childbirth may be a major factor of the development of stress urinary incontinence (SUI) and pelvic organ prolapse (POP). The aim of this study was to prospectively investigate the role of different childbirth strategies on POP and SUI.
METHODS: A total of 120 selected pregnant women were recruited and divided into two groups: vaginal delivery group (n = 72) and selective cesarean delivery group (n = 48). The women were questioned with SUI sheet and estimated with POP quantification (POP-Q) within 6 - 8 weeks after delivery. The correlations of SUI and results of POP-Q with the strategies of delivery were analyzed. t test, chi(2) test, and the Mann-Witney test were used for statistical analysis.
RESULTS: Among the 120 women, SUI was developed during 29 - 30 gestational weeks in 20 patients (16.6%), of whom 14 (70%) had symptoms of SUI till 6 weeks postpartum. Totally 20 (16.6%) women had SUI symptoms after delivery. The prevalence of postpartum SUI was positively correlated with the occurrence of SUI during 29 - 30 gestational weeks (P < 0.001). In the vaginal delivery group, 100% of the women suffered form urinary prolapse 6 weeks postpartum, while 87.5% of those in the selective cesarean delivery group developed POP (P < 0.01). The percentages of the first- and second-degree urinary prolapse in the vaginal delivery group were 20.8% and 79.2% respectively, which were significantly different from those in the selective cesarean delivery group (64.6% and 22.9%; both P = 0.000).
CONCLUSIONS: Pregnancy and delivery play an etiologic role in the development of SUI and POP. The onset of SUI during late pregnancy implies a significant risk of postpartum SUI symptoms. The prevalence of POP is significantly higher after vaginal delivery than after cesarean delivery.

Entities:  

Mesh:

Year:  2008        PMID: 18298911

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  A review of the impact of pregnancy and childbirth on pelvic floor function as assessed by objective measurement techniques.

Authors:  Hans Van Geelen; Donald Ostergard; Peter Sand
Journal:  Int Urogynecol J       Date:  2018-01-13       Impact factor: 2.894

Review 2.  Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors.

Authors:  Godfrey J A Walker; Prasanna Gunasekera
Journal:  Int Urogynecol J       Date:  2010-07-09       Impact factor: 2.894

3.  Pelvic organ support among primiparous women in the first year after childbirth.

Authors:  Victoria L Handa; Ingrid Nygaard; Kimberly Kenton; Geoffrey W Cundiff; Chiara Ghetti; Wen Ye; Holly E Richter
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-09-24

Review 4.  Minimally invasive treatment for female stress urinary incontinence - Romanian highlights.

Authors:  C Surcel; C Chibelean; A Iordache; C Mirvald; C Gîngu; S Margaritis; R Stoica; C Codoiu; C Savu; R Marksteiner; I Sinescu
Journal:  J Med Life       Date:  2011-11-24

5.  Genital prolapse: epidemiology, clinic and therapeutic at Saint Joseph Hospital of Kinshasa.

Authors:  Antoine Tshimbundu Kayembe; Andy Mbangama Muela; Alex Mutombo Baleka; Dieudonné Sengeyi Mushengezi; Rahma Rachid Tozin
Journal:  Pan Afr Med J       Date:  2020-10-29

6.  Factors associated with genital prolapse to Saint Joseph Hospital of Kinshasa.

Authors:  Antoine Tshimbundu Kayembe; Charles Didier Kitenge Kia Kayembe; Jean-Patrick Kamba Bebele; Rahma Rachid Tozin
Journal:  Pan Afr Med J       Date:  2021-12-16

7.  Highlights in the minimally invasive treatment of SUI in women.

Authors:  C Surcel; C Chibelean; A Iordache; C Mirvald; C Gîngu; S Margaritis; R Stoica; C Codoiu; C Savu; R Marksteiner; I Sinescu
Journal:  J Med Life       Date:  2011-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.